42 GENES FOUNDi

Show / hide columns

XML | RDF | TSV | Page of 1

Gene

 

 

Gene description

x

 

 

Protein class

x

 

 

 

 

Tissue

Cell

Pathology

 

 

 

 

 

 

Subcellular location

x

Prognostic p-value

x

 

RNA tissue category

x

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

SIRPGSignal-regulatory protein gammaCD markers
Predicted membrane proteins
Melanoma: 7.36e-7
Endometrial cancer: 1.05e-6
Renal cancer: 1.47e-6
Head and neck cancer: 2.24e-4
Tissue enhanced
HLA-GMajor histocompatibility complex, class I, GCancer-related genes
Predicted membrane proteins
Melanoma: 3.91e-5
Tissue enriched
CD2CD2 moleculeCD markers
FDA approved drug targets
Predicted membrane proteins
Predicted secreted proteins
Renal cancer: 4.82e-6
Endometrial cancer: 1.69e-5
Melanoma: 3.97e-5
Head and neck cancer: 7.46e-5
Cervical cancer: 1.47e-4
Breast cancer: 4.36e-4
Ovarian cancer: 7.72e-4
Tissue enhanced
OTUD7BOTU deubiquitinase 7BEnzymes
Predicted intracellular proteins
Nucleoplasm
Microtubules
Melanoma: 5.09e-5
Endometrial cancer: 7.47e-4
Mixed
LCKLCK proto-oncogene, Src family tyrosine kinaseCancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
Predicted intracellular proteins
Golgi apparatusEndometrial cancer: 2.96e-6
Renal cancer: 2.60e-5
Melanoma: 5.65e-5
Head and neck cancer: 2.91e-4
Tissue enhanced
GNLYGranulysinPredicted intracellular proteins
Predicted secreted proteins
Transporters
Endometrial cancer: 3.48e-5
Melanoma: 6.60e-5
Renal cancer: 1.50e-4
Urothelial cancer: 8.07e-4
Tissue enhanced
NFKB2Nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100)Cancer-related genes
Disease related genes
Predicted intracellular proteins
Transcription factors
Nucleoplasm
Cytosol
Renal cancer: 6.69e-12
Melanoma: 8.45e-5
Colorectal cancer: 3.86e-4
Expressed in all
DLGAP4Discs, large (Drosophila) homolog-associated protein 4Predicted intracellular proteins
Nucleoplasm
Focal adhesion sites
Cytosol
Liver cancer: 3.73e-6
Endometrial cancer: 2.24e-5
Melanoma: 9.88e-5
Renal cancer: 2.48e-4
Expressed in all
CD3ECD3e molecule, epsilon (CD3-TCR complex)CD markers
Disease related genes
FDA approved drug targets
Predicted membrane proteins
Endometrial cancer: 2.30e-6
Renal cancer: 1.12e-5
Melanoma: 1.18e-4
Head and neck cancer: 1.32e-4
Cervical cancer: 1.62e-4
Breast cancer: 1.72e-4
Tissue enhanced
KIF3CKinesin family member 3CPlasma proteins
Predicted intracellular proteins
Nuclear membrane
Nuclear bodies
Intermediate filaments
Endometrial cancer: 1.32e-5
Melanoma: 1.22e-4
Renal cancer: 7.57e-4
Tissue enriched
SLAMF6SLAM family member 6CD markers
Predicted membrane proteins
Renal cancer: 2.09e-6
Head and neck cancer: 7.34e-5
Melanoma: 1.25e-4
Cervical cancer: 2.78e-4
Breast cancer: 9.42e-4
Endometrial cancer: 9.53e-4
Tissue enhanced
NR1D1Nuclear receptor subfamily 1, group D, member 1Nuclear receptors
Predicted intracellular proteins
Transcription factors
Nuclear bodiesMelanoma: 1.36e-4
Colorectal cancer: 1.94e-4
Mixed
PLA2G2APhospholipase A2, group IIA (platelets, synovial fluid)Enzymes
FDA approved drug targets
Predicted secreted proteins
RAS pathway related proteins
Nucleus
Nucleoli
Melanoma: 1.49e-4
Tissue enhanced
SPNSialophorinCD markers
Predicted membrane proteins
Golgi apparatus
Plasma membrane
Cell Junctions
Endometrial cancer: 3.08e-5
Breast cancer: 1.40e-4
Melanoma: 1.88e-4
Tissue enhanced
SDC3Syndecan 3Predicted membrane proteins
Nucleoplasm
Mitochondria
Renal cancer: 1.71e-4
Melanoma: 2.36e-4
Expressed in all
CCL5Chemokine (C-C motif) ligand 5Cancer-related genes
Plasma proteins
Predicted membrane proteins
Predicted secreted proteins
Renal cancer: 3.61e-7
Endometrial cancer: 1.34e-5
Melanoma: 2.42e-4
Tissue enhanced
CD7CD7 moleculeCD markers
Predicted membrane proteins
Predicted secreted proteins
Renal cancer: 7.75e-11
Endometrial cancer: 2.03e-5
Melanoma: 2.69e-4
Cervical cancer: 5.51e-4
Tissue enhanced
CXCR3Chemokine (C-X-C motif) receptor 3CD markers
G-protein coupled receptors
Predicted membrane proteins
Renal cancer: 1.67e-6
Endometrial cancer: 3.44e-6
Melanoma: 2.90e-4
Head and neck cancer: 3.35e-4
Tissue enhanced
HLA-BMajor histocompatibility complex, class I, BCancer-related genes
Predicted intracellular proteins
Predicted membrane proteins
Melanoma: 2.90e-4
Mixed
SELPLGSelectin P ligandCandidate cardiovascular disease genes
CD markers
Plasma proteins
Predicted membrane proteins
Cervical cancer: 1.46e-4
Thyroid cancer: 2.74e-4
Melanoma: 2.92e-4
Renal cancer: 5.86e-4
Head and neck cancer: 6.94e-4
Mixed
WIPI1WD repeat domain, phosphoinositide interacting 1Predicted intracellular proteins
Melanoma: 3.11e-4
Expressed in all
TNFAIP8L2Tumor necrosis factor, alpha-induced protein 8-like 2Predicted intracellular proteins
VesiclesRenal cancer: 3.53e-7
Melanoma: 3.64e-4
Tissue enhanced
BCL3B-cell CLL/lymphoma 3Cancer-related genes
Disease related genes
Plasma proteins
Predicted intracellular proteins
Transcription factors
Nucleoplasm
Vesicles
Midbody
Renal cancer: 3.13e-14
Melanoma: 3.74e-4
Glioma: 5.58e-4
Breast cancer: 9.67e-4
Expressed in all
CD5CD5 moleculeCD markers
Predicted membrane proteins
Predicted secreted proteins
Head and neck cancer: 7.41e-6
Renal cancer: 8.94e-5
Endometrial cancer: 9.00e-5
Cervical cancer: 9.16e-5
Melanoma: 3.93e-4
Breast cancer: 4.05e-4
Tissue enhanced
CCL4Chemokine (C-C motif) ligand 4Cancer-related genes
Predicted secreted proteins
Endometrial cancer: 1.97e-5
Renal cancer: 1.68e-4
Colorectal cancer: 3.54e-4
Melanoma: 3.97e-4
Tissue enhanced
DOK2Docking protein 2, 56kDaPredicted intracellular proteins
Renal cancer: 2.20e-4
Melanoma: 4.31e-4
Mixed
SPOCK2Sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 2Predicted secreted proteins
Nuclear specklesHead and neck cancer: 1.95e-5
Breast cancer: 4.05e-4
Melanoma: 4.72e-4
Ovarian cancer: 7.19e-4
Tissue enhanced
EGR3Early growth response 3Predicted intracellular proteins
Transcription factors
Nucleus
Vesicles
Breast cancer: 1.83e-4
Melanoma: 4.78e-4
Mixed
IDO1Indoleamine 2,3-dioxygenase 1Cancer-related genes
Enzymes
Predicted intracellular proteins
Renal cancer: 1.12e-7
Ovarian cancer: 3.32e-4
Melanoma: 5.27e-4
Tissue enhanced
IKZF3IKAROS family zinc finger 3 (Aiolos)Predicted intracellular proteins
Transcription factors
Plasma membrane
Cytosol
Cervical cancer: 6.85e-6
Head and neck cancer: 4.16e-4
Melanoma: 5.42e-4
Renal cancer: 7.38e-4
Tissue enhanced
CD27CD27 moleculeCancer-related genes
CD markers
Disease related genes
Plasma proteins
Predicted membrane proteins
Head and neck cancer: 6.65e-7
Renal cancer: 1.19e-6
Cervical cancer: 3.77e-5
Endometrial cancer: 2.90e-4
Melanoma: 5.50e-4
Tissue enhanced
ITGALIntegrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide)CD markers
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Renal cancer: 2.69e-5
Endometrial cancer: 5.63e-5
Head and neck cancer: 3.34e-4
Melanoma: 5.57e-4
Tissue enhanced
TAPBPTAP binding protein (tapasin)Plasma proteins
Predicted membrane proteins
Predicted secreted proteins
Breast cancer: 2.76e-4
Melanoma: 6.29e-4
Expressed in all
HCSTHematopoietic cell signal transducerPredicted membrane proteins
VesiclesRenal cancer: 1.59e-10
Melanoma: 6.70e-4
Expressed in all
PGPEP1Pyroglutamyl-peptidase IEnzymes
Predicted intracellular proteins
Golgi apparatusRenal cancer: 3.71e-8
Pancreatic cancer: 1.71e-4
Melanoma: 6.80e-4
Expressed in all
SNTA1Syntrophin, alpha 1Disease related genes
Predicted intracellular proteins
Endometrial cancer: 9.60e-6
Pancreatic cancer: 3.72e-4
Melanoma: 7.08e-4
Expressed in all
C15orf39Chromosome 15 open reading frame 39Predicted intracellular proteins
CytosolRenal cancer: 3.05e-4
Testis cancer: 6.02e-4
Melanoma: 7.94e-4
Tissue enhanced
SIT1Signaling threshold regulating transmembrane adaptor 1Predicted membrane proteins
Endometrial cancer: 1.94e-6
Renal cancer: 1.75e-5
Head and neck cancer: 1.14e-4
Cervical cancer: 6.56e-4
Melanoma: 8.17e-4
Group enriched
SPATA2Spermatogenesis associated 2Predicted intracellular proteins
Nucleus
Nucleoli fibrillar center
Endometrial cancer: 1.87e-4
Thyroid cancer: 4.53e-4
Melanoma: 9.08e-4
Expressed in all
REEP2Receptor accessory protein 2Disease related genes
Predicted membrane proteins
Breast cancer: 7.83e-5
Glioma: 3.43e-4
Melanoma: 9.31e-4
Tissue enriched
BCL2L1BCL2-like 1Cancer-related genes
Predicted intracellular proteins
Predicted membrane proteins
RAS pathway related proteins
Transporters
MitochondriaRenal cancer: 8.89e-5
Pancreatic cancer: 5.87e-4
Endometrial cancer: 9.10e-4
Melanoma: 9.57e-4
Expressed in all
NRTNNeurturinDisease related genes
Predicted secreted proteins
Golgi apparatusEndometrial cancer: 3.86e-4
Head and neck cancer: 7.23e-4
Melanoma: 9.92e-4
Mixed

Page of 1